Objective: This study aimed to review all research evidence of presurgical cleft size and related factors to success of secondary alveolar bone grafting (SABG). Design and Setting: The systematic review searched the OVID-Medline®, PubMed®, Embase®, and Cochrane Central Register of Controlled Trials (CENTRAL) up to August 2020. Two reviewers independently selected potential abstracts for full review. Disagreeements were resolved by consensus. The first author extracted data and assessed the risk of bias using Risk of Bias in Non-randomized studies—of Interventions tool. Patients and Interventions: Patients with non-syndromic clefts who received SABG were selected. Presurgical cleft size/volume and treatment results must be available. Main Outcome Measures: Level of the grafted bone, achievement of orthodontic tooth movement into the grafted area, need for re-operation. Results: From 962 abstracts, 23 publications were included. Mean cleft width was 6.80 ± 1.98 mm, cleft area 20–240 mm2, and mean volume 0.89 ± 0.33 cm3. No definite conclusion was achieved on whether a narrow or wide cleft showed better treatment outcomes, but other potentially related factors were good oral hygiene and eruptive force of the maxillary canines. Lack of a standard definition of cleft size, a small sample size, varying outcome parameters, and moderate-to-high risk of bias contributed to the summary. A meta-analysis could not be performed because of the heterogeneity. Conclusion: Due to insufficient evidence, cleft width/volume could not be specified leading to more successful SABG. Care of patients could be improved in both research by following rigorous methodology, and practice by clear communication.
This study examined the degree of monomer conversion (DC) and mechanical properties of experimental orthodontic adhesives containing monocalcium phosphate monohydrate (MCPM), Sr-bioactive glass (Sr-BAG) nanoparticles, and andrographolide. Experimental adhesives were prepared with a 4:1 powder-to-liquid ratio, containing methacrylate monomers with varying formulations of glass fillers and additives. DC was measured using ATR-FTIR (n = 5) with and without bracket placement under two curing protocols: conventional LED (1200 mW/cm2, 20 s) and high-intensity LED (3200 mW/cm2, 3 s). The biaxial flexural strength and modulus were tested after 4-week water immersion (n = 8). Transbond XT was used as the commercial comparison. Transbond XT exhibited higher DC (33–38%) than the experimental materials. Conventional LED curing produced higher DC than high-intensity LED, while bracket placement reduced DC by approximately 10% in the experimental materials but minimally affected Transbond XT. Transbond XT demonstrated a superior biaxial flexural strength (188 MPa) compared to the experimental adhesives (106–166 MPa, p < 0.05). However, the experimental formulations with low additive concentrations showed a comparable biaxial flexural modulus (5.0–5.5 GPa) to Transbond XT (5.6 GPa) (p > 0.05). Although the experimental adhesives exhibited lower DC and strength than the commercial product, their values still met the ISO standards, suggesting their potential clinical viability despite their modified compositions.